Literature DB >> 21170692

Interactions of Npc1 and amyloid accumulation/deposition in the APP/PS1 mouse model of Alzheimer's.

Ivan A Borbon1, Robert P Erickson.   

Abstract

Although Niemann-Pick C1 disease has frequently been called "juvenile Alzheimer's", the effects of introducing Npc1 mutations into a mouse model of Alzheimer's have not previously been performed. We have crossed Npc1 (+/-) mice with APP/PS1 "Alzheimer's" mice and studied Aβ42 accumulation and amyloid plaque formation. Mice heterozygous for Npc1 and positive for the APP and PS1 transgenes accumulated Aβ42 more rapidly than the APP/PS1 controls and this correlated, as expected, with the area of amyloid plaques. We conclude that the alterations of intracellular cholesterol present in Npc1 (+/-) mice can influence the progress of Alzheimer's disease in the APP/PS1 mouse model.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21170692     DOI: 10.1007/s13353-010-0021-1

Source DB:  PubMed          Journal:  J Appl Genet        ISSN: 1234-1983            Impact factor:   3.240


  46 in total

1.  Accumulation and aggregation of amyloid beta-protein in late endosomes of Niemann-pick type C cells.

Authors:  T Yamazaki; T Y Chang; C Haass; Y Ihara
Journal:  J Biol Chem       Date:  2000-11-20       Impact factor: 5.157

2.  Cholesterol modulates alpha-secretase cleavage of amyloid precursor protein.

Authors:  S Bodovitz; W L Klein
Journal:  J Biol Chem       Date:  1996-02-23       Impact factor: 5.157

3.  Epistasis between intracellular cholesterol trafficking-related genes (NPC1 and ABCA1) and Alzheimer's disease risk.

Authors:  Eloy Rodríguez-Rodríguez; José Luis Vázquez-Higuera; Pascual Sánchez-Juan; Ignacio Mateo; Ana Pozueta; Ana Martínez-García; Ana Frank; Fernando Valdivieso; José Berciano; María J Bullido; Onofre Combarros
Journal:  J Alzheimers Dis       Date:  2010       Impact factor: 4.472

4.  Hypercholesterolemia accelerates the Alzheimer's amyloid pathology in a transgenic mouse model.

Authors:  L M Refolo; B Malester; J LaFrancois; T Bryant-Thomas; R Wang; G S Tint; K Sambamurti; K Duff; M A Pappolla
Journal:  Neurobiol Dis       Date:  2000-08       Impact factor: 5.996

5.  Plaque-derived oxidative stress mediates distorted neurite trajectories in the Alzheimer mouse model.

Authors:  Monica Garcia-Alloza; Sarah A Dodwell; Melanie Meyer-Luehmann; Bradley T Hyman; Brian J Bacskai
Journal:  J Neuropathol Exp Neurol       Date:  2006-11       Impact factor: 3.685

6.  Accelerated Alzheimer-type phenotype in transgenic mice carrying both mutant amyloid precursor protein and presenilin 1 transgenes.

Authors:  L Holcomb; M N Gordon; E McGowan; X Yu; S Benkovic; P Jantzen; K Wright; I Saad; R Mueller; D Morgan; S Sanders; C Zehr; K O'Campo; J Hardy; C M Prada; C Eckman; S Younkin; K Hsiao; K Duff
Journal:  Nat Med       Date:  1998-01       Impact factor: 53.440

7.  Apolipoprotein E isoform phenotyping methodology and population frequency with identification of apoE1 and apoE5 isoforms.

Authors:  J M Ordovas; L Litwack-Klein; P W Wilson; M M Schaefer; E J Schaefer
Journal:  J Lipid Res       Date:  1987-04       Impact factor: 5.922

8.  Altered apolipoprotein E glycosylation is associated with Abeta(42) accumulation in an animal model of Niemann-Pick Type C disease.

Authors:  Ching-Ching Chua; Mei-Li Lim; Boon-Seng Wong
Journal:  J Neurochem       Date:  2010-01-13       Impact factor: 5.372

9.  Genome-wide association study for early-onset and morbid adult obesity identifies three new risk loci in European populations.

Authors:  David Meyre; Jérôme Delplanque; Jean-Claude Chèvre; Cécile Lecoeur; Stéphane Lobbens; Sophie Gallina; Emmanuelle Durand; Vincent Vatin; Franck Degraeve; Christine Proença; Stefan Gaget; Antje Körner; Peter Kovacs; Wieland Kiess; Jean Tichet; Michel Marre; Anna-Liisa Hartikainen; Fritz Horber; Natascha Potoczna; Serge Hercberg; Claire Levy-Marchal; François Pattou; Barbara Heude; Maithé Tauber; Mark I McCarthy; Alexandra I F Blakemore; Alexandre Montpetit; Constantin Polychronakos; Jacques Weill; Lachlan J M Coin; Julian Asher; Paul Elliott; Marjo-Riitta Järvelin; Sophie Visvikis-Siest; Beverley Balkau; Rob Sladek; David Balding; Andrew Walley; Christian Dina; Philippe Froguel
Journal:  Nat Genet       Date:  2009-01-18       Impact factor: 38.330

10.  Intracerebroventricular amyloid-beta antibodies reduce cerebral amyloid angiopathy and associated micro-hemorrhages in aged Tg2576 mice.

Authors:  Deepak R Thakker; Marcy R Weatherspoon; Jonathan Harrison; Thomas E Keene; Deanna S Lane; William F Kaemmerer; Gregory R Stewart; Lisa L Shafer
Journal:  Proc Natl Acad Sci U S A       Date:  2009-02-25       Impact factor: 11.205

View more
  12 in total

1.  Amyloid-β metabolism in Niemann-Pick C disease models and patients.

Authors:  Niklas Mattsson; Maria Olsson; Mikael K Gustavsson; Marko Kosicek; Martina Malnar; Jan-Eric Månsson; Maria Blomqvist; Johan Gobom; Ulf Andreasson; Gunnar Brinkmalm; Charles Vite; Silva Hecimovic; Caroline Hastings; Kaj Blennow; Henrik Zetterberg; Erik Portelius
Journal:  Metab Brain Dis       Date:  2012-09-01       Impact factor: 3.584

Review 2.  Current controversies in Niemann-Pick C1 disease: steroids or gangliosides; neurons or neurons and glia.

Authors:  Robert P Erickson
Journal:  J Appl Genet       Date:  2013-01-05       Impact factor: 3.240

3.  A novel mouse model of Niemann-Pick type C disease carrying a D1005G-Npc1 mutation comparable to commonly observed human mutations.

Authors:  Robert A Maue; Robert W Burgess; Bing Wang; Christine M Wooley; Kevin L Seburn; Marie T Vanier; Maximillian A Rogers; Catherine C Chang; Ta-Yuan Chang; Brent T Harris; David J Graber; Carlos A A Penatti; Donna M Porter; Benjamin S Szwergold; Leslie P Henderson; John W Totenhagen; Theodore P Trouard; Ivan A Borbon; Robert P Erickson
Journal:  Hum Mol Genet       Date:  2011-11-02       Impact factor: 6.150

4.  Relative efficacy of nicotinamide treatment of a mouse model of infantile Niemann-Pick C1 disease.

Authors:  Craig A Marshall; Ivan A Borbon; Robert P Erickson
Journal:  J Appl Genet       Date:  2016-10-25       Impact factor: 3.240

Review 5.  Sphingolipids in neurodegeneration (with focus on ceramide and S1P).

Authors:  Guanghu Wang; Erhard Bieberich
Journal:  Adv Biol Regul       Date:  2018-09-22

Review 6.  Modeling Niemann Pick type C1 using human embryonic and induced pluripotent stem cells.

Authors:  M Paulina Ordoñez; John W Steele
Journal:  Brain Res       Date:  2016-03-10       Impact factor: 3.252

Review 7.  Role of cholesterol in APP metabolism and its significance in Alzheimer's disease pathogenesis.

Authors:  M Maulik; D Westaway; J H Jhamandas; S Kar
Journal:  Mol Neurobiol       Date:  2012-09-16       Impact factor: 5.590

8.  Neurological Dysfunction in Early Maturity of a Model for Niemann-Pick C1 Carrier Status.

Authors:  Ya Hui Hung; Mark Walterfang; Leonid Churilov; Lisa Bray; Laura H Jacobson; Kevin J Barnham; Nigel C Jones; Terence J O'Brien; Dennis Velakoulis; Ashley I Bush
Journal:  Neurotherapeutics       Date:  2016-07       Impact factor: 7.620

Review 9.  Do GWAS and studies of heterozygotes for NPC1 and/or NPC2 explain why NPC disease cases are so rare?

Authors:  Robert P Erickson
Journal:  J Appl Genet       Date:  2018-09-13       Impact factor: 3.240

10.  Disruption in connexin-based communication is associated with intracellular Ca²⁺ signal alterations in astrocytes from Niemann-Pick type C mice.

Authors:  Pablo J Sáez; Juan A Orellana; Natalia Vega-Riveros; Vania A Figueroa; Diego E Hernández; Juan F Castro; Andrés D Klein; Jean X Jiang; Silvana Zanlungo; Juan C Sáez
Journal:  PLoS One       Date:  2013-08-15       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.